Han-Yi Huang

Han-Yi Huang

Auto-generated profile, based on publicly available information

Han-Yi Huang

Global Health Institute, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2022 in Science Translational Medicine
Verified
Journal Article
Open access
HHHan-Yi Huang
Han-Yi Huang
HLHsin-Yu Liao
Hsin-Yu Liao
XCXiaorui Chen
Xiaorui Chen
SWSzu-Wen Wang
Szu-Wen Wang
CCCheng-Wei Cheng
Cheng-Wei Cheng
CWChi-Huey Wong
Chi-Huey Wong
A major challenge to end the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is to develop a broadly protective vaccine that elicits long-term immunity. As the key immunogen, the viral surface spike (S) protein is frequently mutated, and conserved epitopes are shielded by glycans. Here, we revealed that S protein glycosylation has site-differential effects on viral infectivity. We found that S protein generated by lung epithelial cells has glycoforms associated with increased infectivity. Compared to the fully glycosylated S protein, immunization of S protein with N-glycans trimmed to the mono-GlcNAc–decorated state (S MG ) elicited stronger immune responses and better protection for human angiotensin-converting enzyme 2 (hACE2) transgenic mice against variants of concern (VOCs). In addition, a broadly neutralizing monoclonal antibody was identified from S MG -immunized mice that could neutralize wild-type SARS-CoV-2 and VOCs with subpicomolar potency. Together, these results demonstrate that removal of glycan shields to better expose the conserved sequences has the potential to be an effective and simple approach for developing a broadly protective SARS-CoV-2 vaccine.

11 November 2026 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
TDTania Distler
Tania Distler
CTChia-Ni Tsai
Chia-Ni Tsai
HHHan-Yi Huang
Han-Yi Huang
APAlice Pellegrino
Alice Pellegrino
AWAaron Weimann
Aaron Weimann
APAlexandre Persat
Alexandre Persat
During chronic lung infections, Pseudomonas aeruginosa diversifies under selection from antibiotics, metabolic constraints, and host defenses. Macrophages are key sentinels of the innate immune system and play a central role in clearing airway pathogens. Yet, how they process heterogeneous bacterial populations remains poorly understood. Here, we investigate how P. aeruginosa evades phagocytosis under conditions that resemble chronic infection. We use an attenuated mutant lacking a functional type III secretion system (T3SS), which reduces macrophage killing, allowing us to isolate determinants of bacterial susceptibility to phagocytosis. Using transposon insertion sequencing (Tn-seq), we identify bacterial fitness factors under phagocytic selection. Our screen reveals that disruption of genes involved in swimming and twitching motility reduces uptake by macrophages. We find that defects in flagellar and type IV pili (T4P) function interfere with the physical interactions between bacteria and macrophages. Live-cell imaging shows that motility-deficient bacteria exhibit reduced surface accumulation and unstable attachment to macrophages, limiting their internalization. Clinical isolates with reduced swimming or twitching motility display similarly impaired uptake. We also test the influence of bacterial motility on macrophage survival by restoring T3SS activity in flagellar and T4P mutants. In the PAO1 background, most motility mutants retained the ability to kill macrophages indicating that cytotoxicity dominates bacteria-macrophage competition in the presence of a functional T3SS. However, the non-flagellated, hyper-piliated Δ fliC Δ pilT mutant showed a surprisingly attenuated killing, which may reflect reduced bacterial encounters with macrophages, impaired engagement of cytotoxic effectors, or both. Together, our results show that swimming motility and type IV pili shape physical interactions between P. aeruginosa and macrophages, thereby influencing phagocytic uptake.

20 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
HHHan-Yi Huang
Han-Yi Huang
EAElsa N. Astorga-Simon
Elsa N. Astorga-Simon
CAChristopher Adamson
Christopher Adamson
YQYuan Qiao
Yuan Qiao
PNPaula P. Navarro
Paula P. Navarro
APAlexandre Persat
Alexandre Persat
Surface attachment initiates bacterial colonization and biofilm formation, yet remains difficult to target owing to redundant and species-specific mechanisms. Here we identify dalberoside, a natural glycolipid that inhibits adhesion by non-disruptive remodeling of the Gram-negative outer membrane interface. Dalberoside inhibited Pseudomonas aeruginosa and Acinetobacter baumannii attachment and biofilm formation without measurable bactericidal activity or membrane permeabilization. It reduced P. aeruginosa retention on epithelial cells, delayed P. aeruginosa cytotoxicity and rapidly detached surface-associated A. baumannii . High-resolution microscopy of a fluorescent analogue and in situ cryo-electron tomography support a model in which dalberoside associates with the bacterial outer membrane, remodeling its outer leaflet. Biophysical measurements further indicated altered local interfacial properties. Thus, dalberoside reveals the outer membrane interface as a chemically addressable regulator of bacterial surface attachment.